Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury
- 1 October 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 349 (2) , 504-512
- https://doi.org/10.1016/j.bbrc.2006.08.065
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction☆European Journal of Cardio-Thoracic Surgery, 2006
- C1 inhibitor prevents Gram-negative bacterial lipopolysaccharide-induced vascular permeabilityBlood, 2005
- N-Linked Glycosylation Is Required for C1 Inhibitor-Mediated Protection from Endotoxin Shock in MiceInfection and Immunity, 2004
- C1‐Inhibitor Reduces the Ischaemia–Reperfusion Injury of Skeletal Muscles in Mice after Aortic Cross‐ClampingScandinavian Journal of Immunology, 2002
- Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionEuropean Heart Journal, 2002
- Complement activation in heart diseasesCellular Signalling, 2000
- C1 inhibitor in anti-inflammatory therapy: from animal experiment to clinical applicationMolecular Immunology, 1999
- Reperfusion induced injury: manifestations, mechanisms, and clinical relevanceCardiovascular Research, 1992
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990
- Interaction of 125I‐labelled complement subcomponents Cr and Cs with protease inhibitors in plasmaFEBS Letters, 1979